Diabetes mellitus and macrovascular complications. An epidemiological perspective.
about
Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?Molecular mechanisms of ATP and insulin synergistic stimulation of coronary artery smooth muscle growth.Glycemic control and cardiovascular disease in type 2 diabetes: a review.The diabetic foot and leg: combined He-Ne and infrared low-intensity lasers improve skin blood perfusion and prevent potential complications. A prospective study on 30 Egyptian patients.Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience.The pathophysiology of type 2 diabetes mellitus: an overview.Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study.The impact of diabetes on workforce participation: results from a national household sample.Cardiovascular disease in Navajo Indians with type 2 diabetesEnhanced inflammatory responses to toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulinCarotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetesPathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model. The hyperlipemic-hyperglycemic hamsterCardiovascular disease and diabetes: modifying risk factors other than glucose control.Early changes in cardiovascular structure and function in adolescents with type 1 diabetes.Open and Endovascular Treatment of Trans-Atlantic Inter-Society Consensus II D Aortoiliac Occlusive Lesions: What Determines the Rate of Restenosis?Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trialIntensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitusRationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in PrediMacrovascular angiopathy in children and adolescents with type 1 diabetes.Characteristics of peripheral arterial disease and its relevance to the diabetic population.Subclinical vascular endothelial dysfunctions and myocardial changes with type 1 diabetes mellitus in children and adolescents.Dyslipidaemia in non-insulin dependent diabetes: the need for a clinical intervention trial.The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94.The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.Percutaneous transluminal coronary angioplasty or coronary artery bypass grafting for coronary artery disease?Diabetes, mortality and coronary heart disease in the prospective Dubbo study of Australian elderly.Factors associated with the development of renal complications of diabetes mellitus in São Paulo city.Activation of the innate immune system as a predictor of cardiovascular mortality in Type 2 diabetes mellitus.Influence of peripheral vascular calcification on efficiency of screening tests for peripheral arterial occlusive disease in diabetes--a cross-sectional study.Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus.Relationship of highly sensitive C-reactive protein and lipid levels in adolescents with type 1 diabetes mellitus.Association between Vascular Endothelial Markers and Carotid Intima-Media Thickness in Children and Adolescents with Type 1 Diabetes Mellitus.Abnormal nocturnal blood pressure fall in normotensive adolescents with insulin-dependent diabetes is ameliorated following glycemic improvement.Outcomes and risk prediction model for peripheral arterial disease in patients with stable coronary artery disease.Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17-year follow up.Relative nocturnal hypertension in children with insulin-dependent diabetes mellitus.Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn StudyIntravascular ultrasound observations of atherosclerotic lesion formation and restenosis in patients with diabetes mellitus
P2860
Q27009400-2FEF48E8-3834-404F-B206-855743BDEB93Q31833773-EF5E1169-609C-4770-B878-CD1B63BE0CADQ33707377-560A5B5E-6053-4367-BB8A-B3C5C12FF2D9Q33859637-131E2B6E-2DDD-44D3-942E-2CED65008CC6Q33926095-14FE021C-A984-4F27-8A62-F9274CD37250Q34285793-6CC1C677-324D-4C1A-965A-28DC41A14E89Q34307460-4AB8C453-673D-4716-9320-A61B7EE8CC96Q34336889-63161075-C4A1-41D7-B410-5459A7FAD073Q34406173-B54AE077-E2A6-41D6-9D9D-7285A0512BD8Q34478178-006A5CFD-7DE7-4ED5-91AD-23849268CABBQ34721194-386F4DAF-98D3-4ADA-B4AD-5898E85D8C14Q35774329-34FDA44F-2523-4882-A715-8C8D6A3517C1Q36065465-83277B1B-5EDA-4BE3-A041-55C51657EFB5Q36583611-655E68A9-7D15-4C69-B2ED-D21B8ED6A696Q36695935-D457B5D2-E35E-4E68-AC57-048443EEDC47Q36966060-55C5CA3C-E9B3-4818-8C94-443CB8EEEF0FQ37169330-15F23F58-210D-4B9E-A784-11DDD60173F2Q37239783-379FCB7C-8544-4FF7-BD5A-41DE57568149Q37607425-866B232E-0191-4C3F-95B4-254426C77F66Q37857087-D846785B-0E1E-4594-83DC-285F9A182196Q37920503-474F173A-4AC2-43B9-87F2-52393FB99C89Q38992916-9211A34E-E441-44C5-A7A1-2B612EDF8B35Q40656479-DF63ACDD-4C1F-459F-99AB-F8DF4CCAC658Q40814835-4D94B950-021E-4D3C-AA89-E374344AEC65Q41156127-9296E6A1-AE49-4353-8170-2D14DA2818E4Q41589979-A71DBD9D-3568-46DA-BB58-471B4DE9E24BQ44321172-F3AB5004-9253-4E08-ACA1-BA327BA55E3DQ44518647-7166B5A8-D143-4B1E-9C6D-6A6108D3B5E5Q44553379-061291D4-D5A3-4C90-B48A-CABD270E4C40Q44882288-610A8104-3CC9-4A59-8456-B694C71F8593Q46437382-0AF67686-332D-454A-A52B-47B8D62FCF57Q46884194-601F7B0F-DB56-4EEC-812C-1F9CFB5A6839Q47364495-5923AAF3-9220-4892-A58E-95E393072176Q48790958-D2BB1D31-F0F4-43F5-8E1D-D7FE5D57943DQ51019211-FDC157CD-B77E-4689-AACC-713B0A22FDCFQ51567133-E63F7C00-5F45-4978-ABF6-87EB5213892FQ53895282-DBFDF96C-AF7B-4B45-B879-880B63892645Q57830465-378E15EC-2191-43CD-A3F1-3D91526D72A8Q58145267-D653008F-238D-4146-B3E9-83A7A1598021
P2860
Diabetes mellitus and macrovascular complications. An epidemiological perspective.
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Diabetes mellitus and macrovascular complications. An epidemiological perspective.
@ast
Diabetes mellitus and macrovascular complications. An epidemiological perspective.
@en
type
label
Diabetes mellitus and macrovascular complications. An epidemiological perspective.
@ast
Diabetes mellitus and macrovascular complications. An epidemiological perspective.
@en
prefLabel
Diabetes mellitus and macrovascular complications. An epidemiological perspective.
@ast
Diabetes mellitus and macrovascular complications. An epidemiological perspective.
@en
P1433
P1476
Diabetes mellitus and macrovascular complications. An epidemiological perspective.
@en
P2093
Donahue RP
P304
P356
10.2337/DIACARE.15.9.1141
P407
P577
1992-09-01T00:00:00Z